PNV 0.00% $2.39 polynovo limited

Ann: Webcast Recording - Investor Presentation and Update, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,546 Posts.
    lightbulb Created with Sketch. 1971
    "We are looking at alliances globally which can take the NovoSorb into different fields that is not today covered by us.

    We believe we can do a terrific job in (arthro biologics), we are looking at partnerships in general surgery and oncology which can give us representation in different parts of the hospital systems."

    Can anyone else help clarify what Swami was saying when he said "we can do a terrific job in..."

    This does not seem to have been discussed widely here, but I am very interested to see what these partnerships might end up being. We could very well end up partnering with another big company to get into more hospital departments more quickly.

    Swami with his experience at J&D should have a lot of connections to call upon.

    With such big plans and now the extra capital to execute them, I think the next 12-18 months is going to be the start of a transformational period for the company.
    Last edited by Sojourner: 08/12/22
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.39
Change
0.000(0.00%)
Mkt cap ! $1.650B
Open High Low Value Volume
$2.40 $2.41 $2.37 $1.760M 736.4K

Buyers (Bids)

No. Vol. Price($)
4 23241 $2.38
 

Sellers (Offers)

Price($) Vol. No.
$2.39 381 1
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.